MGRX: שווי שוק להכנסות Mangoceuticals Inc.

The development of Mangoceuticals, Inc. (MGRX) is based on MangoRx brand recognition and the optimization of customer acquisition costs. The current P/S ratio reflects the dynamics of these processes, with 10.70 serving as the current metric level. The model is diversified through subscriptions for men's health medications. Steady growth in user loyalty and trust in the service's confidentiality strengthen the brand's modern image.

Aggressive marketing by Mangoceuticals, Inc. (MGRX) and a liquidity shortage make revenue a key indicator of business viability. This metric is calculated as the ratio of market capitalization to annual sales volume, determining the cost of a single dollar of revenue. Through this coefficient, an investor assesses the extent of overpayment for the asset relative to its operational efficiency. Analyzing the price/sales ratio allows for the identification of market bubbles and the avoidance of capital freezes.